Total Revenue: $15.4B Founded Year: 1916 Total Employees: 29,900 Headquarters: Melbourne, Australia Market Cap: $47.64B Stock Exchange: ASX CSL is a global biotechnology company focused on developing and delivering plasma-derived therapies, vaccines, and specialty medicines, operating through key segments like CSL Behring, CSL Seqirus, and CSL Vifor collectively addressing rare diseases, immunology, and infectious diseases
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
Because the supplement industry is not regulated, we do not know what the potential danger might be if these supplements are taken alongside FDA-approved medications, said Dr
She has an MA in modern languages from the University of Edinburgh and previously worked as a translator of European business news for the Financial Times.
Fortunately, this is manageable
Formulated with five novel, next-gen strains, Metabolic Daily uses the same powerful strains of Pendulums flagship product, Glucose Control , but at a dose that benefits metabolic health at a lower price
/product/02/3175523/2.jpg?6062)
